Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oger

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Neurology|March 1, 1990
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluationL F Kastrukoff, J J Oger, S A Hashimoto, et al.
Neurology|February 1, 1988
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CTD W Paty, J J Oger, L F Kastrukoff, et al.
Neurology|November 30, 2000
A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brainG R Moore, E Leung, A L MacKay, et al.
Neurology|March 1, 1996
Depression and multiple sclerosisA D Sadovnick, R A Remick, J Allen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Nature Genetics|August 1, 1996
A full genome search in multiple sclerosisG C Ebers, K Kukay, D E Bulman, et al.
Neurogenetics|August 29, 2001
Genetic susceptibility to MS: a second stage analysis in Canadian MS familiesD A Dyment, C J Willer, B Scott, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Neurology|March 1, 1990
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluationL F Kastrukoff, J J Oger, S A Hashimoto, et al.
Neurology|February 1, 1988
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CTD W Paty, J J Oger, L F Kastrukoff, et al.
Neurology|November 30, 2000
A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brainG R Moore, E Leung, A L MacKay, et al.
Neurology|March 1, 1996
Depression and multiple sclerosisA D Sadovnick, R A Remick, J Allen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Nature Genetics|August 1, 1996
A full genome search in multiple sclerosisG C Ebers, K Kukay, D E Bulman, et al.
Neurogenetics|August 29, 2001
Genetic susceptibility to MS: a second stage analysis in Canadian MS familiesD A Dyment, C J Willer, B Scott, et al.
Pageof 13